Nilotpal Sanyal

Dr. Nilotpal Sanyal

Mathematical Sciences, The University of Texas at El Paso, El Paso, Texas, USA
orcid
Assistant Professor

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MLMin-Tzu Lo
Min-Tzu Lo
DHDavid A Hinds
David A Hinds
JTJoyce Y Tung
Joyce Y Tung
CFCarol Franz
Carol Franz
CFChun-Chieh Fan
Chun-Chieh Fan
CCChi-Hua Chen
Chi-Hua Chen

1 June 2021 in Journal of Thoracic Oncology
Verified
Journal Article
Open access
JAJacqueline V. Aredo
Jacqueline V. Aredo
SLSophia J. Luo
Sophia J. Luo
RGRebecca M. Gardner
Rebecca M. Gardner
Nilotpal SanyalNilotpal Sanyal
Nilotpal Sanyal
ECEunji Choi
Eunji Choi
SHSummer S. Han
Summer S. Han
Lung cancer survivors are at high risk of developing a second primary lung cancer (SPLC). However, SPLC risk factors have not been established and the impact of tobacco smoking remains controversial. We examined the risk factors for SPLC across multiple epidemiologic cohorts and evaluated the impact of smoking cessation on reducing SPLC risk. We analyzed data from 7059 participants in the Multiethnic Cohort (MEC) diagnosed with an initial primary lung cancer (IPLC) between 1993 and 2017. Cause-specific proportional hazards models estimated SPLC risk. We conducted validation studies using the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (N = 3423 IPLC cases) and European Prospective Investigation into Cancer and Nutrition (N = 4731 IPLC cases) cohorts and pooled the SPLC risk estimates using random effects meta-analysis. Overall, 163 MEC cases (2.3%) developed SPLC. Smoking pack-years (hazard ratio [HR] = 1.18 per 10 pack-years, p < 0.001) and smoking intensity (HR = 1.30 per 10 cigarettes per day, p < 0.001) were significantly associated with increased SPLC risk. Individuals who met the 2013 U.S. Preventive Services Task Force's screening criteria at IPLC diagnosis also had an increased SPLC risk (HR = 1.92; p < 0.001). Validation studies with the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial and European Prospective Investigation into Cancer and Nutrition revealed consistent results. Meta-analysis yielded pooled HRs of 1.16 per 10 pack-years (pmeta < 0.001), 1.25 per 10 cigarettes per day (pmeta < 0.001), and 1.99 (pmeta < 0.001) for meeting the U.S. Preventive Services Task Force's criteria. In MEC, smoking cessation after IPLC diagnosis was associated with an 83% reduction in SPLC risk (HR = 0.17; p < 0.001). Tobacco smoking is a risk factor for SPLC. Smoking cessation may reduce the risk of SPLC. Additional strategies for SPLC surveillance and screening are warranted.

1 December 2019 in Neurobiology of Aging
Verified
Journal Article
Closed access
MLMin-Tzu Lo
Min-Tzu Lo
KKKarolina Kauppi
Karolina Kauppi
CFChun-Chieh Fan
Chun-Chieh Fan
Nilotpal SanyalNilotpal Sanyal
Nilotpal Sanyal
EREmilie T. Reas
Emilie T. Reas
CCChi-Hua Chen
Chi-Hua Chen

1 November 2012 in NeuroImage
Verified
Journal Article
Closed access
Nilotpal SanyalNilotpal Sanyal
Nilotpal Sanyal
MFMarco A.R. Ferreira
Marco A.R. Ferreira

19 June 2018 in Bioinformatics
Verified
Journal Article
Closed access
Nilotpal SanyalNilotpal Sanyal
Nilotpal Sanyal
MLMin-Tzu Lo
Min-Tzu Lo
KKKarolina Kauppi
Karolina Kauppi
SDSrdjan Djurovic
Srdjan Djurovic
OAOle A Andreassen
Ole A Andreassen
CCChi-Hua Chen
Chi-Hua Chen
Motivation: Multiple marker analysis of the genome-wide association study (GWAS) data has gained ample attention in recent years. However, because of the ultra high-dimensionality of GWAS data, such analysis is challenging. Frequently used penalized regression methods often lead to large number of false positives, whereas Bayesian methods are computationally very expensive. Motivated to ameliorate these issues simultaneously, we consider the novel approach of using non-local priors in an iterative variable selection framework.Results: We develop a variable selection method, named, iterative non-local prior based selection for GWAS, or GWASinlps, that combines, in an iterative variable selection framework, the computational efficiency of the screen-and-select approach based on some association learning and the parsimonious uncertainty quantification provided by the use of non-local priors. The hallmark of our method is the introduction of ‘structured screen-and-select’ strategy, that considers hierarchical screening, which is not only based on response-predictor associations, but also based on response-response associations and concatenates variable selection within that hierarchy. Extensive simulation studies with single nucleotide polymorphisms having realistic linkage disequilibrium structures demonstrate the advantages of our computationally efficient method compared to several frequentist and Bayesian variable selection methods, in terms of true positive rate, false discovery rate, mean squared error and effect size estimation error. Further, we provide empirical power analysis useful for study design. Finally, a real GWAS data application was considered with human height as phenotype.Availability and implementation: An R-package for implementing the GWASinlps method is available at https://cran.r-project.org/web/packages/GWASinlps/index.html.Supplementary information: Supplementary data are available at Bioinformatics online.

1 July 2018 in American Journal of Psychiatry
Verified
Journal Article
Closed access
KKKarolina Kauppi
Karolina Kauppi
SRSara Brin Rosenthal
Sara Brin Rosenthal
MLMin-Tzu Lo
Min-Tzu Lo
Nilotpal SanyalNilotpal Sanyal
Nilotpal Sanyal
MJMian Jiang
Mian Jiang
CCChi-Hua Chen
Chi-Hua Chen